HSA
CVS icon

Hussman Strategic Advisors’s CVS Health CVS Stock Holding History

Hussman Strategic Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Sell
25,200
-16,800
-40% -$1.5M 0.6% 63
2026
Q1 		$3.02M Hold
42,000
– – 0.65% 35
2025
Q4 		$3.33M Buy
+42,000
New +$3.31M 0.81% 13
2025
Q3 		– Sell
-31,500
Closed -$2.17M – 295
2025
Q2 		$2.17M Buy
+31,500
New +$2.07M 0.5% 80
2025
Q1 		– Sell
-63,000
Closed -$2.83M – 259
2024
Q4 		$2.83M Hold
63,000
– – 0.84% 26
2024
Q3 		$3.96M Buy
63,000
+42,000
+200% +$2.45M 0.97% 10
2024
Q2 		$1.24M Buy
+21,000
New +$1.31M 0.34% 122
2024
Q1 		– Sell
-21,000
Closed -$1.66M – 237
2023
Q4 		$1.66M Sell
21,000
-8,400
-29% -$598K 0.38% 106
2023
Q3 		$2.05M Sell
29,400
-7,000
-19% -$496K 0.39% 102
2023
Q2 		$2.52M Hold
36,400
– – 0.46% 67
2023
Q1 		$2.7M Hold
36,400
– – 0.42% 88
2022
Q4 		$3.39M Sell
36,400
-800
-2% -$77.2K 0.55% 61
2022
Q3 		$3.55M Sell
37,200
-9,300
-20% -$921K 0.61% 41
2022
Q2 		$4.31M Buy
46,500
+30,900
+198% +$3.02M 0.74% 24
2022
Q1 		$1.58M Hold
15,600
– – 0.31% 130
2021
Q4 		$1.61M Buy
+15,600
New +$1.44M 0.35% 108
2021
Q2 		– Sell
-21,600
Closed -$1.63M – 351
2021
Q1 		$1.63M Sell
21,600
-19,400
-47% -$1.41M 0.33% 108
2020
Q4 		$2.8M Buy
41,000
+5,300
+15% +$345K 0.73% 30
2020
Q3 		$2.08M Sell
35,700
-15,150
-30% -$943K 0.55% 59
2020
Q2 		$3.3M Buy
50,850
+25,100
+97% +$1.58M 0.84% 6
2020
Q1 		$1.53M Buy
+25,750
New +$1.72M 0.41% 90
2019
Q3 		– Sell
-35,000
Closed -$1.91M – 200
2019
Q2 		$1.91M Sell
35,000
-800
-2% -$43.1K 0.53% 84
2019
Q1 		$1.93M Hold
35,800
– – 0.47% 86
2018
Q4 		$2.35M Buy
+35,800
New +$2.67M 0.57% 71

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Hussman Strategic Advisors's CVS Position: Q2 2026 in Review

Hussman Strategic Advisors reduced its CVS Health (CVS) stake by 40% in Q2 2026, selling an estimated $1.5M and leaving 25,200 shares worth $2.61M. The position accounts for 0.6% of the portfolio, ranked #63.

Hussman Strategic Advisors first reported a position in CVS in Q4 2018 and has held it in 24 quarters since. The position peaked at $4.31M in Q2 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Hussman Strategic Advisors held 25,200 shares of CVS Health worth $2.61M as of Q2 2026.
  • Hussman Strategic Advisors sold 16,800 CVS Health shares in Q2 2026, an estimated $1.5M.
  • CVS Health made up 0.6% of Hussman Strategic Advisors's portfolio in Q2 2026, its #63 holding.
  • Hussman Strategic Advisors first reported a position in CVS Health in Q4 2018 and has held it in 24 quarters since.
  • Hussman Strategic Advisors's CVS Health position peaked at $4.31M in Q2 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.